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NF-B is a key activator of inflammatory and immune responses
with important pathological roles in cancer, heart disease, and
autoimmune diseases. Transcriptional activity of NF-B is regulated
by different posttranslational modifications. Here, we report a
novel mechanism of NF-B regulation through lysine monomethy-
lation by SET9 methyltransferase. Set9 specifically methylates p65
at lysine 37. Both TNF and IL-1 treatments induced methylation
of p65. Methylated p65 is restricted to the nucleus and this
modification regulates the promoter binding of p65. Moreover,
Set9 mediated methylation of p65 is required for the expression of
a subset of NF-B target genes in response to TNF stimulation.
methylation  SET9
NF-B is a transcription factor that plays a pivotal role inregulating multiple biological functions including inflam-
mation, immunity, cell proliferation, and apoptosis. NF-B
represents a group of evolutionarily conserved and structurally
related proteins. The 5 members of the mammalian NF-B, p65
(RelA), RelB, cRel, p50/p105 (NF-B1), and p52/p100 (NF-
B2), form homo- or heterodimers that bind to IB family
proteins in unstimulated cells (1). NF-B is sequestered in the
cytoplasm through its interaction with the IB in resting cells.
Stimulation of cells with a variety of ligands, such as tumor
necrosis factor- (TNF), interleukin-1 (IL-1), or pathogen-
associated molecular patterns (PAMPs), leads to the rapid
phosphorylation of IB by the IB kinase complex (IKK). The
IKK kinase complex contains 2 catalytic subunits, IKK and
IKK, and the regulatory subunit, IKK. IKK catalyzes the
phosphorylation of IB at 2 serine residues in the N terminus.
The phosphorylated IB becomes ubiquitinated and subse-
quently degraded by 26S proteasome, thereby allowing NF-B to
enter the nucleus to turn on a large array of target genes (1, 2).
Although the activity of NF-B is regulated by nuclear trans-
location, covalent modifications of the protein by various events
including phosphorylation, ubiquitination, nitrosylation, and
acetylation can affect its activity (3). These regulatory modifi-
cations have distinct functional consequences. For example,
acetylation of p65 at K218 and K221 inhibits IB binding and
enhances DNA-binding (4) whereas acetylation of p65 at K122
and K123 inhibits its transcriptional activating activity (5).
Proteins can be posttranslationally methylated at lysine, argi-
nine, histidine, and dicarboxylic amino acids by highly specific
methyltransferases (6). In the process of protein-lysine methyl-
ation, the addition of methyl groups to the -amine of a lysine
residue results in the formation of mono-, di-, or trimethyllysine.
This process can be reversed by demethylases. Histone is one of
the best studied proteins that undergoesmethylation (7). Specific
sites of methylation on histones correlate with either activation
or repression of transcription. Recently, several transcription
factors, including p53 (8, 9), STAT1 (10), RAR (11), and ER
(12), have been shown to be methylated and their biological
activity modified by the modification.
Set9 (also known as Set7) was initially purified as a H3K4
histone methyltransferase from HeLa nuclear extracts (13, 14).
Biochemical and structural studies suggest that Set9 catalyzes
monomethylation of H3K4 (15, 16). In addition, Set9 has been
shown to methylate several nonhistone proteins such as p53 (8),
TAF10 (17), and ER (12). Methylation of p53 and ER results in
the stabilization of these proteins and the transcriptional acti-
vation. On the other hand, methylation of TAF10 increases the
binding to RNA polymerase II. These results collectively suggest
that Set9-mediated methylation of proteins other than histone
may be more general.
In the present report, we demonstrate that NF-B is also
regulated by methylation. We show that p65 is monomethylated
by Set9 at lysine 37. Both TNF and IL-1 treatments induced
methylation of p65. Methylated p65 is restricted to the nucleus.
Moreover, Set9 catalyzed methylation of p65 is required for the
induction of a subset NF-B regulated genes. Methylation of p65
affects the stability of DNA-p65 complexes, which in turn
regulates the recruitment of p65 to the promoter.
Results
NF-B Is Regulated by Methylation. To test whether NF-B is
regulated by methylation, we blocked methylation reactions in
cells with a broad methylation inhibitor, 5-deoxy-5-
methylthioadenosine (MTA) (18) and observed that it inhibited
the TNF-induced response of an NF-B-driven luciferase
reporter in a dose-dependent manner (Fig. 1A). To further
investigate the role of methylation in the NF-B pathway, we
examined IB degradation and p65 nuclear translocation, 2 key
steps in NF-B activation. HEK293 cells were treated with or
without MTA (1 mM) for 1 h; cytoplasmic and nuclear extracts
were prepared after treatment with TNF for various time
points. We found that MTA-treatment blocked neither the
degradation of IB nor the nuclear translocation of p65,
indicating MTA inhibits a step in NF-B activation that is
independent of the nuclear translocation process (Fig. 1B).
Set9 Methylates p65 in Vitro. We then tested whether p65 can be
methylated in vitro. It has been shown that Set9 methylates
histone H3 (13, 14) and several nonhistone proteins such as p53
(8), TAF10 (17), and ER (12). We therefore purified recombi-
nant Set9 from bacteria and tested whether it could methylate
p65 in vitro. Using recombinant p65 fragments that cover all of
the lysine residues of p65 as substrates, we performed in vitro
methylation and found that the N terminus (1–110) of p65 was
methylated by Set9 in vitro (Fig. 2A). Set9-mediated methylation
was specific to p65, as p50 was not methylated under the same
experimental condition (Fig. 2A). There are 6 lysine residues
within this region, K28, K37, K56, K62, K79, and K93. To map
the methylation site, we substituted each of these lysines with
nonmethylatable arginines. A single point mutation at lysine 37
(K37) completely abolished the methylation by Set9 (Fig. 2B),
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suggesting that Set9 methylates p65 at K37. Lysine 37 is highly
conserved from Drosophila to humans and is present only in p65
and c-Rel among NF-B family proteins (Fig. 2C). Using p65
peptides (residues 33–41) with unmodified, mono-, di- or tri-
methylated K37, we further showed that Set9 only methylated
unmodified p65 peptide suggesting that Set9 monomethylates
p65 (Fig. 2D). This is consistent with studies showing that Set9
is exclusively a monomethyltransferase (15, 16).
Set9 Methylates p65 in Vivo. To facilitate studies on the role of
Set9 methylation of p65 in vivo, we generated a polyclonal
antibody that specifically recognized monomethylated p65 at
K37 (p65K37me1). Rabbit antibodies were purified against
unmodified-p65 peptide (negative selection) followed by
monomethylated-p65 peptide (positive selection). The puri-
fied antibodies specifically recognized monomethylated p65-
peptide, but failed to detect unmodified, di-, and trimethyl-
ated-p65 peptides (Fig. 3A).
To test whether p65K37me1 antibody recognized methylated-
p65 in vivo, we overexpressed Flag-tagged wild-type p65 or
Flag-p65K37Q in HEK293 cells. Flag immunoprecipitates were
subjected to Western blot analysis with p65K37me1 and anti-
Flag antibodies. The p65K37me1 antibody was able to detect
wild-type p65 but not the K37Q mutant (Fig. 3B, lanes 1 and 2).
Moreover, detection of p65 by the antibody to p65K37me1 was
greatly reduced when the cells were treated with MTA for 4 h
(lanes 3 and 4). These results showed that p65K37me1 antibody
detects the monomethylation of p65 at K37. More importantly
these results indicate that p65 is methylated in vivo. To demon-
strate that the methylation of p65 was mediated by Set9, we used
RNA interference to silence the expression of Set9 in HEK293
cells and then transfected the cells with wild-type p65 or K37Q
mutant expression vectors. A small interfering RNA (siRNA)
targeted to Set9 decreased the expression of Set9 protein but not
the expression of p65 (Fig. 3C, Lower panel). Overexpression of
wild-type p65 led to methylation of p65 in cells transfected with
control siRNA (Fig. 3C, Upper panel). In contrast, methylation
of p65 was significantly reduced when Set9 was knocked down by
siRNA, suggesting that Set9 is the major methyltransferase that
monomethylates p65 at K37 in vivo.
We then examined whether Set9 could methylate endogenous
p65 in response to TNF stimulation. HEK293 cells were treated
with control or Set9-specific siRNAs. Cytoplasmic and nuclear
extracts were prepared from TNF-treated and untreated cells
followed by p65 immunoprecipitation. TNF stimulation did
induce methylation of p65 at K37 but the methylated p65 was
only detected in the nucleus (Fig. 3D). Moreover, knockdown of
expression of Set9 completely abolished the TNF-induced
methylation of p65. These in vivo data support our in vitro
findings that Set9 monomethylates p65 at K37.
To test whether another NF-B agonist induces methylation of
p65 at K37, we treated HeLa cells with IL-1 for various time
periods. We fractionated cell lysates into cytoplasmic and nu-
clear factions followed by p65 immunoprecipitation. Similar to
TNF stimulation, IL-1 treatment led to methylation of p65 at
K37 (Fig. 3E). In addition, methylated p65 was again only
present in the nuclear fraction. These findings collectively sug-
gested that methylation of p65 in response to different forms of
NF-B stimulation is a general phenomenon, rather than a
cell-type or agonist-specific event.
Set9 Is Required for the Expression of a Subset NF-B-Regulated
Genes in Response to TNF Stimulation. To characterize the phys-
iological function of Set9-mediated p65-K37 methylation, we
evaluated the effects of Set9 loss of function on TNF-induced
NF-B-regulated gene expression. We silenced the expression of
Set9 by RNAi, using 2 targeted siRNAs. Each of the siRNAs
Fig. 1. (A) MTA inhibits TNF-induced NF-B activation. HEK293 cells were
transfected with a NF-B-driven luciferase reporter. Twenty-four hours later,
the cells were pretreated with or without various concentrations of MTA for
1 h. The cells were then treated with or without TNF for 12 h. The luciferase
activity was measured and normalized for transfection efficiency as deter-
mined by cotransfection of a constitutively expressed -galactosidase re-
porter. (B)MTAdoes not affect IB degradation or p65 nuclear translocation
in response to TNF stimulation. HEK293 cells were treated with or without
MTA (1 mM) for 1 h, cytoplasmic and nuclear extracts were prepared after
treatment with TNF for various time points as indicated, and were immuno-
blotted with indicated antibodies.
Fig. 2. Set9 methylates p65 at K37 in vitro. (A) Autoradiogram (Top) and
Ponceau S staining (Bottom) of in vitro methylation assay with recombinant
Set9 and recombinant p65 fragments. (B) In vitro methylation assay with p65
(1–110) bearing K28R, K37R, K56R, K62R, K79R, and K93R substitutions. (C)
Alignment of protein sequences adjacent to K37 among different species
(Top) and NF-B family members (Bottom). h, human; m, mouse; r, rat; x,
Xenopus. (D) Autoradiograph (Top) of methylation assay with p65 peptides
(33–41) containing unmodified (K37), monomethylated (K37Me1), dimethy-
lated (K37Me2), and trimethylated (K37Me3) K37. Ponceau S staining of the
methylation gel is shown above (Bottom).
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achieved 90% knockdown of Set9 mRNA as measured by
RT-PCR (Fig. 4A, Left panel). TNF-induced expression of both
IP-10 and TNF was reduced by 5060% in cells transfected
with Set9-specific siRNAs. In contrast, the induction of IBwas
not affected by knocking down Set9 expresssion. Similar results
were obtained using HeLa cells (supporting information (SI)
Fig. S1, Top Left panel). These results imply that Set9 is
important for the expression of a subset NF-B-dependent gene
in response to TNF stimulation. This finding is consistent with
a recent microarray study showing that SET9 is required for the
induction of 25% of genes activated by NF-B in TNF-treated
human monocytes (19). To further investigate the role of Set9 in
the NF-B pathway, we examined IB degradation and p65
nuclear translocation, 2 key steps in NF-B activation. We
prepared cytoplasmic and nuclear extracts from Set9 knockdown
and control HEK293 cells after treatment of TNF for various
time points. As expected, TNF induced degradation of IB and
nuclear translocation of p65 in control cells. Neither of these
steps was affected by silencing the expression of Set9 (Fig. 4B).
These results indicate that Set9 might regulate the nuclear
function of p65.
Set9 Regulates DNA Binding and Promoter Recruitment of p65. To
examine whether Set9 regulates the DNA binding of p65, we
used the electrophoretic mobility shift assay (ESMA) with
nuclear extracts prepared from cells transfected with control or
Set9-specific siRNAs. As indicated in Fig. 4C (Left panel), TNF
induced strong p65 DNA binding in both control and Set9-
deficient extracts. With 2 probes, 1 containing the NF-B
binding site found in Ig (Fig. 4C), the other in the IL-8
promoter (Fig. S2), we observed no differences between control
and Set9-depleted samples. However, when we increased the salt
concentration in the EMSA reactions to 300 mM, there was a
slightly reduced level of DNA-p65 complex formation in the
control and a 35% further drop in the Set9-deficient extracts.
Using an Oct1 probe, the increased salt had the same effect with
or without Set9. (Fig. 4C Middle and Right panels). This result
suggests that Set9 regulates the stability of DNA-p65 complexes,
which might account for the reduction of expression of several
genes in TNF-treated Set9-deficient cells. To explore this pos-
Fig. 3. Set9 methylates p65 in vivo. (A) Dotblot analysis with p65K37me1
antibody on p65 peptides. (B) Detection of p65K37me1 by Western blot.
Expression vectors encoding Flag-p65 or Flag-p65 K37Q were transfected
into HEK293 cells. Twenty-four hours later, cells were treated with or
without MTA (1 mM) for 4 h. Eluates from Flag immunoprecipitation were
subjected toWestern blot analysis with p65 (Bottom) and p65K37me1 (Top)
antibodies. (C) HEK293 cells were transfected with control or Set9-specific
siRNAs. A day later the cells were retransfected with siRNAs along with
Flag-p65 or Flag-p65K37Q. The cells were harvested the next day and
eluates from Flag immunoprecipitation were analyzed with p65 and
p65K37me1 antibodies. (D) HEK293 cells transfected with control or Set9-
specific siRNAs were stimulated with TNF and fractionated. P65 immuno-
precipitates from cytoplasmic or nuclear extracts were immunoblotted
with p65K37me1 (Top) or p65 (Bottom) antibodies. (E) HeLa cells were
treated with or without IL-1 for the indicated time periods, and p65
immunoprecipitates from cytoplasmic or nuclear extracts were immuno-
blotted with p65K37me1 (Top) or p65 (Bottom) antibodies.
Fig. 4. Set9 is required for TNF-induced expression of a subset of NF-B-
depedent genes. (A) HEK293 cells transfected with control or Set9-specific
siRNAs were stimulated with or without TNF for 12 h. Expression of Set9,
IB, TNF, and IP-10 weremeasured by RT-PCR. (B) SET9 does not affect IB
degradation or p65 nuclear translocation in response to TNF stimulation.
Cytoplasmic and nuclear extracts prepared from Set9 knockdown and control
HEK293 cells after treatment of TNF for various timepoints as indicatedwere
immunoblotted with indicated antibodies. (C) Five micrograms of nuclear
extracts from B were subjected to EMSA. Various salt concentrations were
used to test the stability of p65-DNA complexes (Middle panel; 100 mM NaCl
in the Left panel). Intensity of the bands was quantified using ImageQuant
(GE); means of 3 independent experiments are shown in the Right panel (D)
control, p65 and Set9 siRNAs transfected HeLa cells were treated with or
without TNF for the indicated time periods, and ChIP assays were performed
with anti-p65 antibody. ChIP-enriched samples were analyzed by regular PCR
using IP-10, TNF, and IBpromoter and exon primers. Intensity of the bands
was quantified using ImageQuant and labeled as fold induction. Figures
represent data from 2 independent experiments.
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sibility, we analyzed the recruitment of p65 to promoters of
IB, IP-10, and TNF by chromatin immunoprecipitation
(ChIP). As shown in Fig. 4D, p65 was recruited to promoters
of IB, IP-10, and TNF in response to TNF stimulation.
The recruitment of p65 to these promoters was abolished in the
p65 siRNA transfected cells. On the other hand, in the absence
of Set9, p65 was recruited to the promoter of IB but not to
the promoters of IP-10 and TNF. The amount of p65
recruited to the IB promoter was slightly less (1520%) in
Set9-deficient cells. However the slight reduction of p65 bound
to IB did not affect the induction of IB by TNF
stimulation (Fig. 4A). These data suggest that methylation by
Set9 regulates the affinity of p65 for DNA, which is a critical
parameter for induction of a subset of NF-B-dependent genes
in response to TNF stimulation.
K37Methylation of p65 Is Required for the Induction of a Subset NF-B
Regulated Genes. To determine whether Set9 regulates the func-
tion of p65 specifically through K37 methylation, p65–/ MEF
cells were infected with retroviruses encoding either wild-type
p65 or p65K37Q. Stable reconstituted cell lines were established
by puromycin selection. The expression level of wild type p65 and
p65K37Q were comparable between 2 cell lines as determine by
RT-PCR and Western blot (Fig. 5 A and B). Next we treated the
cells with TNF and measured expression of several NF-B-
dependent genes by RT-PCR. Consistent with the effects of Set9
loss of function, induction of IP-10 and TNF was greatly
reduced in p65K37Q-reconstituted cells, whereas the induction
of IB was not affected (Fig. 5A). Furthermore, we prepared
cytoplasmic and nuclear extracts from wild-type p65- and
p65K37Q-reconstituted cells treated with or without TNF and
found that the IB degradation and the nuclear translocation
of p65 were not affected in p65K37Q-reconstituted cells (Fig.
5B). We next analyzed whether methylation of p65 affects its
DNA binding by EMSA.We performed EMSA using the nuclear
extracts prepared as described in Fig. 4B. As expected, the
nonmethylatable p65K37Q mutant formed less stable DNA-p65
complexes than the wild-type p65 (39% less, Fig. 5C) whereas no
difference was observed when using Oct1 probe.
Although Set9 was first identified as a histone methyltrans-
ferase that monomethylates H3K4 (13, 14), it has been shown
that Set9 is unable to methylate H3K4 assembled into nucleo-
somes (8). Furthermore, we noticed that neither silencing the
expression of Set9 by RNAi nor TNF stimulation affects the
global level of H3K4me1 modification (Fig. S3A). More im-
portantly the presence of H3K4me1 modification did not
correlate with induction of TNF and IP-10 in response to
TNF stimulation (Fig. S3B). As shown in Fig. S4B, H3K4me1
modification was detected at the promoters of TNF and IP-10
in resting cells as determined by ChIP even though the mRNAs
of these genes were barely detectable. Although TNF stim-
ulation induced the expression of IP-10 and TNF, it failed to
further increase H3K4m1 modification at their promoters. In
contrast, p65 bound to these promoters only after TNF
stimulation. These findings support the idea that Set9-
mediated K37 methylation of p65 but not H3K4 is required for
maximal transcriptional activation of p65.
Fig. 5. Methylation of p65 is critical for p65 function. (A) P65/ MEF cells reconstituted with p65 or p65K37Q were treated with TNF for 12 h. Expression of
p65, IB, TNF, and IP-10 was determined with RT-PCR. (B) Cytoplasmic and nuclear fractions from p65/ MEF cells reconstituted with p65 or p65K37Q
stimulated with TNF for various time periods were subjected to immunoblotting with the indicated antibodies. (C) Five micrograms of nuclear extracts from
Bwere subjected to EMSA. Intensity of the bands was quantified using ImageQuant; means of 3 independent experiments were shown in the Right panel. (D)
Models of the mechanism of control by Set9-mediated methylation of p65: (i) P65 fails to form stable DNA-p65 complex on a subset of promoters (eg., TNF,
and IP-10) without methylation at K37. (ii) Methylation of p65 at K37 stabilizes the formation of DNA-p65 complex at the promoter. (iii) Methylation of p65 at
K37 creates a docking site for recruiting coactivator X that leads to formation of a functional enhanceosome.
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Discussion
In this study, we report a signal-dependent methylation of p65.
We showed that Set9 mediates methylation of p65 in response to
TNF and IL-1 stimulation. Furthermore, Set9-catalyzed
methylation of p65 is required for the induction of a subset of
NF-B-regulated genes. Methylation of p65 affects the stability
of DNA-p65 complexes, which in turn regulates the recruitment
of p65 to the promoter. What is the mechanism for methylation-
induced stabilization of DNA-p65 complexes? One of the pos-
sibilities is that K37 is within the loop structure of p65 that is
critical for its DNA binding. Several amino acids adjacent to K37
have been shown to interact directly with DNA (20). Although
K37 does not interact directly with DNA, methylation of K37
may change the conformation of the loop and increase the
stability of the DNA-p65 complexes (Fig. 5D).
Another possibility is that the methylation of K37 creates a
docking site to recruit a coactivator (Fig. 5D). Several protein
domains, such as Tudor, Chromo, MBT, and PHD domain, have
been identified as methylated-lysine binding domains (21). Most
proteins containing these domains are involved in epigenetic
modification and regulation of chromosomal structure. In addi-
tion, different coactivators have been shown to regulate induc-
tion of different subsets of NF-B regulated genes. For example,
we have previously shown that IRF3 and Bcl3 function as
coactivator for induction of IP-10 but not MCP-1 in response to
LPS and TNF stimulation, respectively (22), while others have
reported that RPS-3 is critical for induction of a subset of NF-B
regulated genes upon TCR stimulation (23). Methylation of p65
may serve as direct or indirect interacting interface for recruiting
these coactivators to form an enhanceosome to activate gene
transcription. Either model could lead to less stable DNA-p65
interactions because a coactivator could stabilize the complex.
Further experimentation will be needed to differentiate among
these possibilities.
Two recent reports have also shown that NF-B is regulated
by Set9 (19, 24). In the first article, the authors show that Set9
regulates the expression of a subset of NF-B regulated genes in
response to TNF stimulation (19), which is consistent with our
findings. However, the authors failed to detect any methylation
of p65 using a commercially available methylated-lysine-specific
antibody and they concluded that the histone methyltransferase
activity of Set9 modulates NF-B downstream genes. We ac-
quired several commercially available methylated-lysine-specific
antibodies and showed that none of them were able to detect p65
peptides withmonomethylated K37 (Fig. S4). On the other hand,
our highly specific p65K37me1 antibody enables us to directly
detect methylation of p65 in vivo. Althoughmethylation of H3K4
has been linked to transcriptional activation in a variety of
eukaryotic species, it is the di- and trimethylation of H3K4 that
are enriched at the promoter of active genes (21). Furthermore,
it has been shown that Set9 catalyzed exclusively monomethy-
lation of H3K4. More importantly, we show that the presence
of monomethylation of H3K4 at the promoters of TNF and
IP-10 does not correlate with the expression of TNF and IP-10
(Fig. S3B).
In the second study, the authors show that Set9 methylates p65
at K315 and K316 and negatively regulates the transcriptional
activity of p65 (24). The differences in the in vitro data might
result from different epitope tags used in generating the recom-
binant p65 fragments. For example, the N-terminal GST tag used
in the study might block the access of Set9 to K37 while
GST-induced dimerization might facilitate the methylation of
K315 and K316. The in vivo methylation results are more
controversial as the antibody used in the study recognized
dimethylated lysine according to the company Website (http://
www.abcam.com/pan-methyl-Lysine-methyl-K-pan-antibody-
ChIP-Grade-ab7315.html) whereas both K315 and K316 are
monomethylated by Set9 (24). Furthermore, we tested the same
antibody against p65 peptides (residues 33–41) with unmodified,
mono-, di- or trimethylated K37 and found that the antibody
recognized exclusively the dimethylated K37 p65 peptide (Fig.
S4). Finally, different cellular contexts may determine the role
of Set9 in regulating p65. In THP-1 (19), HEK293, and HeLa
cells, Set9 functions as a positive regulator whereas in U2OS and
A549 cells it functions as a negative regulator. One possible
explanation is that in THP-1, HEK293, and HeLa cells K37
methylation of p65 is exclusively catalyzed by Set9, whereas in
the other 2 types of cells it can also be catalyzed by other
methyltransferases. In fact, we found that knocking down the
expression of Set9 in U2OS cells has little or no effect on
TNF-induced methylation of p65 at K37 (Fig. S5). Moreover, the
methylation of K37 has faster kinetics (peaks at 30 min, Fig. 3
D and E) than the methylation of K315 and K316 (peaks at 60
min) (24). Thus it is likely that K37 modification occurs before
K315 and K316 modification. Although K37 methylation is
required for the gene activation, K315 and K316 methylation
is required for the termination of NF-B activity. Further
experimentation will be needed to fully understand these rela-
tionships.
Materials and Methods
Antibodies. Antibodies against p65 (F6, C20), IB (C21), PARP (5A5), and
-tubulin (TU-02)were purchased from Santa Cruz Biotechnology. Antibodies
against FLAG (M2, Sigma), HA (Covance), H3K4me1 (Abcam), and Set9 (Up-
state Laboratories) were purchased from the respective commercial sources.
Peptides. The following peptides were chemically synthesized for antibody
production and dot blot analysis: P65 unmodified, NH2-RFRYKCEGR-COOH;
p65monomethyl-K37, NH2-RFRYK-(Me)CEGR-COOH; p65dimethyl-K37, NH2-
RFRYK-(Me2)CEGR-COOH; and p65 trimethyl-K37, NH2-RFRYK-(Me3)CEGR-
COOH.
Methylation Assay. The samples were incubated at 30 °C for 60 min in a
reaction buffer containing 50 mM Tris-HCl (pH 8.5), 5 mMMgCl2, 4 mM DTT,
and 1 M 3H-labeled SAM (Amersham Pharmacia Biotech). Onemicrogram of
His6-p65 or GST–p65 fusion proteinswere used as substrates. The total volume
of a reaction mixture was adjusted to 10 L. The reaction was stopped by the
addition of SDS sample buffer and then fractionated on a 15% SDS/PAGE.
Separated His6 or GST fusion proteins were then transferred onto an Immo-
bilon-P membrane (Millipore) and visualized by the Ponceau S staining. The
membranewas sprayedwith theEN3HANCE (NEN) andexposed toKodakXAR
film overnight.
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